Hippokratis Kiaris
Hippokratis Kiaris
Unknown affiliation
Verified email at cop.sc.edu - Homepage
Cited by
Cited by
Mutations of ras genes in human tumors
International journal of oncology 7 (3), 413-421, 1995
Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice
A Klinakis, M Szabolcs, K Politi, H Kiaris, S Artavanis-Tsakonas, ...
Proceedings of the National Academy of Sciences 103 (24), 9262-9267, 2006
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities
DC Porter, E Farmaki, S Altilia, GP Schools, DK West, M Chen, BD Chang, ...
Proceedings of the National Academy of Sciences 109 (34), 13799-13804, 2012
Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival
JK Field, H Kiaris, JM Risk, C Tsiriyotis, R Adamson, V Zoumpourlis, ...
British journal of cancer 72 (5), 1180-1188, 1995
Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium
H Kiaris, K Politi, LM Grimm, M Szabolcs, P Fisher, A Efstratiadis, ...
The American journal of pathology 165 (2), 695-705, 2004
Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis
H Kiaris, I Chatzistamou, G Trimis, M Frangou-Plemmenou, A Pafiti-Kondi, ...
Cancer research 65 (5), 1627-1630, 2005
Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck
H Kiaris, DA Spandidos, AS Jones, ED Vaughan, JK Field
British journal of cancer 72 (1), 123-128, 1995
Microsatellite instability in squamous cell carcinoma of the head and neck
JK Field, H Kiaris, P Howard, ED Vaughan, DA Spandidos, AS Jones
British journal of cancer 71 (5), 1065-1069, 1995
Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma
H Kiaris, AV Schally, JL Varga, K Groot, P Armatis
Proceedings of the National Academy of Sciences 96 (26), 14894-14898, 1999
Microsatellite instability and loss of heterozygosity in human pterygia
DA Spandidos, G Sourvinos, H Kiaris, J Tsamparlakis
British journal of ophthalmology 81 (6), 493-496, 1997
Evaluation of Re and 99mTc Complexes of 2-(4′-Aminophenyl)benzothiazole as Potential Breast Cancer Radiopharmaceuticals
S Tzanopoulou, M Sagnou, M Paravatou-Petsotas, E Gourni, G Loudos, ...
Journal of medicinal chemistry 53 (12), 4633-4641, 2010
Notch3 marks clonogenic mammary luminal progenitor cells in vivo
D Lafkas, V Rodilla, M Huyghe, L Mourao, H Kiaris, S Fre
Journal of Cell Biology 203 (1), 47-56, 2013
Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone …
VJ Csernus, AV Schally, H Kiaris, P Armatis
Proceedings of the National Academy of Sciences 96 (6), 3098-3103, 1999
Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone
H Kiaris, AV Schally
Proceedings of the National Academy of Sciences 96 (1), 226-231, 1999
Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques
J Hatzistamou, H Kiaris, M Ergazaki, DA Spandidos
Biochemical and biophysical research communications 225 (1), 186-190, 1996
Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer
MSJ McDermott, AA Chumanevich, C Lim, J Liang, M Chen, S Altilia, ...
Oncotarget 8 (8), 12558, 2017
A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice
H Kiaris, AV Schally, A Nagy, K Szepeshazi, F Hebert, G Halmos
European journal of cancer 37 (5), 620-628, 2001
Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice
H Kiaris, AV Schally, JL Varga
Neoplasia 2 (3), 242-250, 2000
Growth hormone-releasing hormone: not only a neurohormone
H Kiaris, I Chatzistamou, AG Papavassiliou, AV Schally
Trends in Endocrinology & Metabolism 22 (8), 311-317, 2011
Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status
K Szepeshazi, AV Schally, G Halmos, P Armatis, F Hebert, B Sun, A Feil, ...
Cancer research 62 (3), 781-788, 2002
The system can't perform the operation now. Try again later.
Articles 1–20